Inspire Medical Systems, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $912.0M | $802.8M | $624.8M | $407.9M | $233.4M |
| Gross profit | $778.8M | $679.8M | $528.2M | $341.7M | $200.1M |
| Operating income | $51.0M | $36.1M | -$40.3M | -$47.6M | -$39.9M |
| Operating expenses | — | — | $568.5M | $389.3M | $240.0M |
| Cost of revenue | $133.2M | $123.0M | $96.6M | $66.1M | $33.3M |
| Cash from operations | $117.0M | $130.2M | $24.7M | $11.6M | -$20.1M |
| Capital expenditure | $38.5M | $39.1M | $23.6M | $9.1M | $4.7M |
| Free cash flow | $78.5M | $91.1M | $1.0M | $2.5M | -$24.8M |
| Share repurchases | $175.0M | $0 | $0 | $0 | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $907.3M | $808.4M | $676.8M | $564.9M | $295.1M |
| Total liabilities | $126.2M | $118.7M | $104.3M | $68.9M | $66.0M |
Shares outstanding 28.8M · Free float 97.7%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.